One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease

• Behzad Najafian ,

  * E-mail: najafian@uw.edu

  Affiliation Department of Pathology, University of Washington, Seattle, United States of America

  ⨯
• Camilla Tøndel,

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Pediatrics, Haukeland University Hospital, Bergen, Norway

  ⨯
• Einar Svarstad,

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Medicine, Haukeland University Hospital, Bergen, Norway

  ⨯
• Alexey Sokolovkiy,

  Affiliation Department of Pathology, University of Washington, Seattle, United States of America

  ⨯
• Kelly Smith,

  Affiliation Department of Pathology, University of Washington, Seattle, United States of America

  ⨯
• Michael Mauer

  Affiliation Departments of Pediatrics and Medicine, University of Minnesota, Minneapolis, United States of America

  ⨯